Why Biotech Teams Trust Siggly
From pre-clinical research to commercialization, Siggly adapts to every stage of the biotech lifecycle.
FDA & EMA Credential Fields
Include IND/NDA submission references, EMA authorization numbers, and regulatory contact details that reviewers and partners expect to see.
Research Collaboration Links
Add ORCID profiles, PubMed author pages, and institutional affiliation links so collaborators can verify your publication record instantly.
Confidentiality Disclaimers
Automatically append HIPAA, trade-secret, and proprietary-information disclaimers to signatures used in sensitive communications.
Clinical Trial Banners
Promote active clinical trials, patient recruitment drives, and ClinicalTrials.gov listings through rotating banner campaigns in employee signatures.
Accelerate Your Biotech Communications
Regulatory Readiness
Signatures that include proper disclaimers and credential formatting help your team stay audit-ready at all times.
Peer Review Visibility
ORCID and PubMed links in signatures make it easy for collaborators and journal editors to find your published research.
Investor Relations
Pipeline milestone banners and investor deck links in executive signatures keep stakeholders informed passively.
"After deploying Siggly, our regulatory affairs team no longer worries about missing disclaimers. Every email to the FDA includes the proper credential block and confidentiality notice."
Dr. Anita Sharma
VP of Regulatory Affairs, Helix Therapeutics